Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric Patients
NCT03880214 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2019-03-20
Summary
our aim is estimating the Prevalence and predicting risk factors for developing chronic oral graft versus host disease in pediatric patients subjected to hematopoietic stem cells transplantation
Conditions
- Oral Disease
- Graft-versus-host-disease
- Stem Cell Transplant Complications
- Pediatric Disorder
Sponsors & Collaborators
-
yasmeen magdi sholkamy
lead OTHER
Principal Investigators
-
basma abd el alim · Lecturer at Department of Oral Medicine and periodontology Cairo University
Eligibility
- Min Age
- 3 Years
- Max Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-30
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
More Related Trials
-
Experience of Having Chronic Graft-Versus-Host Disease
NCT00353106 ·Status: COMPLETED
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
NCT06649201 ·Status: RECRUITING
-
Modification of the Human Colon and Oral Microbiome by Allogenic HSCT
NCT03942159 ·Status: UNKNOWN
-
Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease
NCT01036958 ·Status: COMPLETED
-
Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults
NCT00912067 ·Status: UNKNOWN
-
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
NCT05170347 ·Status: RECRUITING
-
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
NCT02338479 ·Status: UNKNOWN
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA
-
The Association of Microbiota Composition With cGVHD After Allo-HSCT
NCT05355675 ·Status: UNKNOWN
-
Oral Complications After Haematopoietic Stem Cell Transplantation: a Retrospective Study
NCT05595070 ·Status: UNKNOWN
-
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
NCT04372524 ·Status: RECRUITING
-
Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease
NCT02055625 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
NCT03532971 ·Status: COMPLETED
-
Assessment of Efficacy of LightWalker (Nd:Yag, Er:Yag) Laser Therapy on Incidence, Severity and Duration of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT). Prospective Randomized Open-label Study
NCT05175222 ·Status: COMPLETED ·Phase: NA
-
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
NCT02398708 ·Status: COMPLETED
-
Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03233659 ·Status: COMPLETED
-
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
NCT04098445 ·Status: RECRUITING
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
Multidisciplinary Intervention In Chronic GVHD
NCT04479995 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT
NCT06334367 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03605953 ·Status: UNKNOWN